VerifiedRx
Delivering short doses of insight for hospitals’ frontline pharmacy professionals, Vizient pharmacy leader Gretchen Brummel brings together experts to verify best practices for navigating today’s pharmacy practice challenges and accelerating career growth. It’s a prescription for success, delivered by the Vizient Center for Pharmacy Practice Excellence.
Listen on:
Episodes
Tuesday Nov 08, 2022
Tuesday Nov 08, 2022
Dr. John Schoen and Dr. Emily Diehl share the complexities and very real potential for errors of the various COVID-19 vaccines. Multiple platforms, volumes, indications, as well as the dilution and storage instructions all contribute to the risk.
Guest speakers:John Schoen, PharmD, BCPSSenior Clinical Manager of Drug Information Vizient
Emily Diehl, PharmD, BCPPSPharmacy Executive Director for CHA Vizient
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[00:53-02:22] Emily and John’s backgrounds
[02:23-07:04] What’s been happening with COVID-19 Vaccines
[07:05-14:53] The concerns right now for adults and children vaccines
[14:54-21:07] What can be done to mitigate the risks
[20:08-22:34] Go to resources when you need clarity
Links | Resources:
Verified Rx: What’s new with pneumococcal vaccines?
CDC Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States
ISMPErrors with COVID Vaccines Lead ISMP’s of Medication Safety Concerns from 2021
Additional risk of age-related mix-ups now that our youngest patients are eligible for COVID-19 vaccines
Age-Related COVID-19 Vaccine Mix-Ups
FDA – EUA page for CV19 Click Here
ASHP – American Society of Health-System Pharmacy Click Here
AAFP – American Academy Family Physicians CV19 resources Click Here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Tuesday Oct 25, 2022
Tuesday Oct 25, 2022
Carolyn Liptak, Pharmacy Executive Director at Vizient shares her expertise on Medication diversion in today’s health care environment. Diversion is a complex and pervasive issue that challenges health systems and creates significant impacts.
Guest speakers:Carolyn Liptak, MBA, RPhPharmacy Executive Director Vizient
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[01:11-02:35] Why drug diversion is an important issue
[02:36-05:47] Drug diversion technology over the years
[05:48-08:11] How drug diversion software assists in the process
[08:12-10:30] Other gaps in detection
[10:31-12:06] What frontline staff should know about diversion
[12:07-13:21] DEA Drug Take Back Day
Links | Resources:
DEA Drug Takeback Day
HeathcareDiversion.org
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Tuesday Oct 11, 2022
Tuesday Oct 11, 2022
Susan Wescott, MBA, Executive Lead of Clinical Services at Alluma discusses her insights on how clinical collaboration between a health plan and ambulatory pharmacists is an effective equation for improved outcomes and savings.
Guest speaker:Susan Wescott, RPh, MBAExecutive Lead of Clinical Services Alluma
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[01:45 - 05:02] Why Mayo Clinic ventured into this space
[05:03 - 08:00] What about biosimilars
[08:01 -10:18] What differentiates Alluma’s approach
[10:19 -12:35] How the pandemic impacted Alluma’s patients
[12:36 -15:30] How can Frontline Pharmacy staff utilize this in their daily work?
[15:31 -17:38] Where this is moving in the future
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Tuesday Sep 20, 2022
Tuesday Sep 20, 2022
Dr. Mandy Leonard, Senior Director of Drug Use Policy and Formulary Management at Cleveland Clinic and Steven Lucio, Senior Principal in Pharmacy Solutions at Vizient discuss their insights on the approval, role, and coverage of Aducanumab, the first drug in a new class approved for Alzheimer’s by the FDA’s accelerated approval process.
Guest speakers:Mandy Leonard, PharmD, BCPSSenior Director of Drug Use Policy and Formulary Management Cleveland Clinic
Steven Lucio, PharmD, BCPSSenior Principal in Pharmacy Solutions Vizient
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[00:47 -3:06] Other factors driving aducanumab formulary decision making
[03:07-6:35] How CMS is managing this medication
[06:36-9:04] What should patients and families know about this medication?
[09:05-12:33] What frontline pharmacists should know about this medication
Links | Resources:
To use Aduhelm or not to use Aduhelm- that is the question…now what is the evidence? Part 1
EMERGE and ENGAGE
American Academy of Neurology statement
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Tuesday Sep 13, 2022
Tuesday Sep 13, 2022
Dr. Mandy Leonard, Senior Director of Drug Use Policy and Formulary Management at Cleveland Clinic and Steven Lucio, Senior Principal in Pharmacy Solutions at Vizient discuss their insights on the approval, role, and coverage of Aducanumab, the first drug in a new class approved for Alzheimer’s by the FDA’s accelerated approval process.
Guest speakers:Mandy Leonard, PharmD, BCPSSenior Director of Drug Use Policy and Formulary Management Cleveland Clinic
Steven Lucio, PharmD, BCPSSenior Principal in Pharmacy Solutions Vizient
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[01:20 -4:16] How aducanumab fits into the treatment of Alzheimer's disease
[04:17-8:29] Accelerated Approval process and Aducanumab
[08:30-14:38] Aducanumab trials and efficacy
[14:39-17:24] Aducanumab trials and safety
Links | Resources:
EMERGE and ENGAGE
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Tuesday Aug 09, 2022
Tuesday Aug 09, 2022
Dr. James Braun, Neurosciences Pharmacy Clinical Specialist at SSM Health St. Louis, and Dr. Kyle Hoelting, Senior Manager of Drug Information at Vizient, continue to share their insights on the use of TNK vs Alteplase for treating acute ischemic stroke. They also discuss the nuances of this therapeutic area and share recent work from an expert panel led by Vizient.
Guest speakers:James Braun, PharmD, BCCCPNeurosciences Pharmacy Clinical Specialist SSM Health
Kyle Hoelting, PharmD, BCPSSenior Manager of Drug Information Vizient
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[00:30-3:59] Medication safety risks associated with thrombolytics
[04:00-4:42] Using one drug over another
[04:43-6:48] How frontline pharmacy staff can utilize this information
[06:49-11:44] What Vizient can add to the discussion
[11:45-11:55] When report will be released
Links | Resources:
Tenecteplase vs alteplase in acute ischemic stroke: Vizient expert panel
Verified Rx: Evidenced based medicine Click here
Verified Rx: Show me the data! Updates on the evidence of thrombolytic use in ischemic strokes Click here
Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 1 Click here
Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 2 Click here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Wednesday Jul 27, 2022
Wednesday Jul 27, 2022
Dr. Carina Dolan, Editor in Chief of Vizient’s Pharmacy Market Outlook and Senior Director of Clinical Oncology and Pharmaceutical Outcomes at Vizient, shares insights on the Summer 2022 Vizient Pharmacy Market Outlook with host Gretchen Brummel. Dr. Dolan discusses the outlook’s projection, impact of inflation, and ways that frontline staff can use the report.
Guest speakers:Carina Dolan, PharmD, MS, BCOPSenior Director of Clinical Oncology and Pharmaceutical Outcomes Vizient
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[00:45-1:21] Final Projection for this issue
[01:22-1:57] Highlights from this issue
[01:58-2:48] How inflation currently impacts drug prices and projections
[02:49-3:34] How frontline staff can use outlook
[03:35-4:16] Unexpected trends emerging
[04:17-5:03] Key forecast issues
[05:04-5:35] Where listeners can go for more detailed information
Links | Resources:
Vizient Pharmacy Market Outlook Member link: Click Here
Vizient Pharmacy Market Outlook highlights public version: Click Here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Tuesday Jul 12, 2022
Tuesday Jul 12, 2022
Dr. James Braun, Neurosciences Pharmacy Clinical Specialist at SSM Health St. Louis, and Dr. Kyle Hoelting, Senior Manager of Drug Information at Vizient, share their insights on the use of tenecteplase vs alteplase for treating acute ischemic stroke. They also discuss the nuances of this therapeutic area and share recent work from an expert panel led by Vizient.
Guest speakers:James Braun, PharmD, BCCCPNeurosciences Pharmacy Clinical Specialist SSM Health
Kyle Hoelting, PharmD, BCPSSenior Manager of Drug Information Vizient
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[00:58-3:00] James’ background and his role in the treatment of stroke patients
[03:01-5:09] History of tenecteplase and alteplase for ischemic stroke
[05:10-6:56] Information about trials of alteplase
[06:57-8:11] Where Tenecteplase fits in discussion
[08:12-9:51] Differences with tenecteplase and alteplase to clinicians
[9:52-12:00] What studies say about potential, practical advantages of tenecteplase
[12:01-19:55] Making the switch between agents
Links | Resources:
Verified Rx: Evidenced based medicine Click here
Verified Rx: Show me the data! Updates on the evidence of thrombolytic use in ischemic strokes Click here
Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 1 Click here
Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 2 Click here
Identifying errors and safety considerations in patients undergoing thrombolysis in acute ischemic stroke Click here
EXTEND-IA TNK Click here
Australian-TNK Click here
Meta-analysis NIHSS outcomes Click here
NOR-TEST Click here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Tuesday Jun 28, 2022
Tuesday Jun 28, 2022
Dr. David Aguero, Director, Medication Systems and Informatics, and Dr. Ben Moore, Pharmaceutical Data Analytics Coordinator at St. Jude Children’s Research Hospital winners of the Vizient Pharmacy Vision Award for excellence in pharmacy analytics, discuss their program that used analytics to design a program that positioned pharmacy as an internal service line with defined business goals with host Gretchen Brummel.
Guest speakers:David Aguero, PharmD, MSTL, dPLADirector, Medication Systems and Informatics St. Jude Children’s Research Hospital
Ben Moore, PharmD, MSPharmaceutical Data Analytics Coordinator St. Jude Children’s Research Hospital
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[01:13-2:42] Background information on pharmaceutical services, informatics, analytics team at St Jude
[02:43-5:23] Building the governance structure at St. Jude
[05:24-7:39] The problem that needed solving
[07:40-10:00] Ultimately, what did they want to accomplish
[10:01-13:58] Approaches that address the issues
[13:59-16:25] Deliverables they were able to reduce as part of this work, and who are their end users
[16:26-18:03] Discovering other opportunities
[18:04-19:48] Outcomes from the work
[19:49-20:44] Role of analytics in health care, specifically in pharmacy
[20:45-21:29] Future plans
[21:30-22:37] Advice for frontline pharmacy staff
Links | Resources:
Vizient Pharmacy Vision Awards: Click here
Video
All winners
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed
Tuesday Jun 21, 2022
Tuesday Jun 21, 2022
Dr. Shirley Wong, Clinical Program Pharmacist, and Dr. Stephanie Hsia, Assistant Professor of Clinical Pharmacy at UCSF, winners of the Vizient Pharmacy Vision Award for Excellence in clinical practice, discuss their program helped UCSF to reach a system wide goal of 73% blood pressure control in our African American population and close the disparity in hypertension control with host Gretchen Brummel.
Guest speakers:Shirley Wong, PharmD, CGPClinical Program Pharmacist UCSF
Stephanie Hsia, PharmD, MAEd, BCPS, BCPPAssistant Professor of Clinical Pharmacy UCSF
Moderator:Gretchen Brummel, PharmD, BCPSPharmacy Executive DirectorVizient Center for Pharmacy Practice Excellence
Show Notes:
[01:01-2:15] What were they trying to accomplish
[02:16-6:14] Approach to address the problem
[06:15-6:55] What's included in their collaborative practice agreement
[06:56-08:37] Pharmacist training requirements to provide these services
[08:38-09:55] Impact of the work on patient outcomes
[09:56-11:49] Other opportunities discovered along the way
[11:50-12:58] Are successes going to encourage other tele-pharmacy programs
[12:59-14:18] Other ways this program influenced patient satisfaction
[14:19-14:50] Future plans
[14:51-15:54] Advice for frontline pharmacy staff
Links | Resources:
Vizient Pharmacy Vision Awards: Click here
Video - https://youtu.be/HHtD-83ld0E
All award winners
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed